Correction: 🔬 Tackling the IBS problem

32 Biosciences takes gut health seriously Recently launched   32 Biosciences Hey {NAME}, We hope this message finds you well. We are reaching out to address a correction regarding a recent email you received titled "🔬 Tackling the IBS problem". In our communication sent out, there was an error regarding one of the statements. We stated that the company was developing the first diagnostic test, which was incorrect. The accurate information is that the company is developing the first-in-class diagnostic test. We would like to apologize for any confusion that this may have caused. Our team is dedicated to providing accurate and timely information, and we appreciate your understanding in this matter. ~/AAQRxQA~/RgRod8KIP0S-aHR0cHM6Ly9yZXB1YmxpYy5jb20vMzJiaW9zY2llbmNlcz91dG1fc291cmNlPXJlcHVibGljLmNvbSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1sYXVuY2hfYSZ1dG1fY29udGVudD1mNWU1OGQyNy1kOTVhLTQ2YzItYmUxYy1mNDQ0NzdkYmY0YzJfYWxsJnV0bV90ZXJtPTMyYmlvc2NpZW5jZXMmbGlkPXpyYjNzcWx2NTh2eFcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~   Raised $88K+   Minimum investment $300 Medical experts are increasingly aware that imbalances in the gut microbiome - a condition known as Dysbiosis - are a contributing factor to all kinds of diseases. There’s Irritable Bowel Syndrome, a problem that more than 20 million Americans suffer from, as well as links to Parkinson’s, Alzheimer’s, Diabetes, hypertension, obesity, and, most prominently. Yet there’s been no established way to identify Dysbiosis. That’s where [32 Biosciences](~/AAQRxQA~/RgRod8KIP0S-aHR0cHM6Ly9yZXB1YmxpYy5jb20vMzJiaW9zY2llbmNlcz91dG1fc291cmNlPXJlcHVibGljLmNvbSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1sYXVuY2hfYSZ1dG1fY29udGVudD1mNWU1OGQyNy1kOTVhLTQ2YzItYmUxYy1mNDQ0NzdkYmY0YzJfYWxsJnV0bV90ZXJtPTMyYmlvc2NpZW5jZXMmbGlkPXBlZ3h5ZnN0NGcwNlcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~) comes in. The NIH has already recognized the importance of their research with a $2.3 million Fast Track Grant. The company is developing the first-in-class diagnostic test, derived from over 100,000 metabolic signals, that measures the functional health of the gut microbiome.   ~/AAQRxQA~/RgRod8KIP0S-aHR0cHM6Ly9yZXB1YmxpYy5jb20vMzJiaW9zY2llbmNlcz91dG1fc291cmNlPXJlcHVibGljLmNvbSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1sYXVuY2hfYSZ1dG1fY29udGVudD1mNWU1OGQyNy1kOTVhLTQ2YzItYmUxYy1mNDQ0NzdkYmY0YzJfYWxsJnV0bV90ZXJtPTMyYmlvc2NpZW5jZXMmbGlkPXdoNmphcTZlYzg0ZlcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~ Experienced leadership Founders include former J&J and Abbott Executives   Proven track record Scientific founders have received $90M in NIH funding   World-class partners Partnerships with Johns Hopkins Medicine, Cleveland Clinic, JP Morgan Chase, and many more   32 Biosciences work isn’t stopping at diagnosis. They’re also developing a new type of medicine by preventing genes known to cause dangerous bacterial infections from ever “turning on." At the same time, it strengthens the gut’s natural defenses by feeding the gut microbiome helpful bacteria to enhance overall health. To aid the development process, they’ve also established partnerships with leading research institutions like Johns Hopkins and Cleveland. Learn more about [32 Biosciences and their pioneering research](~/AAQRxQA~/RgRod8KIP0S-aHR0cHM6Ly9yZXB1YmxpYy5jb20vMzJiaW9zY2llbmNlcz91dG1fc291cmNlPXJlcHVibGljLmNvbSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1sYXVuY2hfYSZ1dG1fY29udGVudD1mNWU1OGQyNy1kOTVhLTQ2YzItYmUxYy1mNDQ0NzdkYmY0YzJfYWxsJnV0bV90ZXJtPTMyYmlvc2NpZW5jZXMmbGlkPWkwYmlueHFyZW9hOVcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~)~/AAQRxQA~/RgRod8KIP0S-aHR0cHM6Ly9yZXB1YmxpYy5jb20vMzJiaW9zY2llbmNlcz91dG1fc291cmNlPXJlcHVibGljLmNvbSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1sYXVuY2hfYSZ1dG1fY29udGVudD03ZWU0NmQ3ZS0zOWM3LTRhMjQtYmVhNC04NjdjNjIzNDUxYTJfYWxsJnV0bV90ZXJtPTMyYmlvc2NpZW5jZXMmbGlkPWw5NjliaDBubWZvZFcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~~/AAQRxQA~/RgRod8KIP0S-aHR0cHM6Ly9yZXB1YmxpYy5jb20vMzJiaW9zY2llbmNlcz91dG1fc291cmNlPXJlcHVibGljLmNvbSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1sYXVuY2hfYSZ1dG1fY29udGVudD03ZWU0NmQ3ZS0zOWM3LTRhMjQtYmVhNC04NjdjNjIzNDUxYTJfYWxsJnV0bV90ZXJtPTMyYmlvc2NpZW5jZXMmbGlkPW9tcm05N3U4NHk0dFcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~. ~/AAQRxQA~/RgRod8KIP0S-aHR0cHM6Ly9yZXB1YmxpYy5jb20vMzJiaW9zY2llbmNlcz91dG1fc291cmNlPXJlcHVibGljLmNvbSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1sYXVuY2hfYSZ1dG1fY29udGVudD1mNWU1OGQyNy1kOTVhLTQ2YzItYmUxYy1mNDQ0NzdkYmY0YzJfYWxsJnV0bV90ZXJtPTMyYmlvc2NpZW5jZXMmbGlkPW50dG1nbzVyaGJ5aVcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~ ~/AAQRxQA~/RgRod8KIP0S-aHR0cHM6Ly9yZXB1YmxpYy5jb20vMzJiaW9zY2llbmNlcz91dG1fc291cmNlPXJlcHVibGljLmNvbSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1sYXVuY2hfYSZ1dG1fY29udGVudD1mNWU1OGQyNy1kOTVhLTQ2YzItYmUxYy1mNDQ0NzdkYmY0YzJfYWxsJnV0bV90ZXJtPTMyYmlvc2NpZW5jZXMmbGlkPWdwcTQ1MWEwZmRjaFcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~ [View 32 Biosciences on Republic](~/AAQRxQA~/RgRod8KIP0S-aHR0cHM6Ly9yZXB1YmxpYy5jb20vMzJiaW9zY2llbmNlcz91dG1fc291cmNlPXJlcHVibGljLmNvbSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1sYXVuY2hfYSZ1dG1fY29udGVudD1mNWU1OGQyNy1kOTVhLTQ2YzItYmUxYy1mNDQ0NzdkYmY0YzJfYWxsJnV0bV90ZXJtPTMyYmlvc2NpZW5jZXMmbGlkPWllaTY5Zmd1dzVwcVcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~)   [Instagram](~/AAQRxQA~/RgRod8KIP0Q-aHR0cHM6Ly93d3cuaW5zdGFncmFtLmNvbS9qb2lucmVwdWJsaWMvP2hsPWVuJmxpZD1zYTZ2bTdkcTk5NnBXA3NwY0IKZpKIPZVmFeJcllIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO) [LinkedIn](~/AAQRxQA~/RgRod8KIP0RHaHR0cHM6Ly93d3cubGlua2VkaW4uY29tL2NvbXBhbnkvcmVwdWJsaWMuY28vbXljb21wYW55P2xpZD11YTZmM2N6Z2poNmZXA3NwY0IKZpKIPZVmFeJcllIbdHJpc3RyYW1iYWxkd2luOTBAZ21haWwuY29tWAQAAAHO) [Twitter](~/AAQRxQA~/RgRod8KIP0QxaHR0cHM6Ly90d2l0dGVyLmNvbS9qb2lucmVwdWJsaWM_bGlkPXQ4ZDNnb3Q0NThwelcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~) [YouTube](~/AAQRxQA~/RgRod8KIP0RJaHR0cHM6Ly93d3cueW91dHViZS5jb20vY2hhbm5lbC9VQ21QdUNNbzhmVk50cTRJeHdPX291V0E_bGlkPXMxdTJheGdhdmxidlcDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~) ~/AAQRxQA~/RgRod8KIP0RXaHR0cHM6Ly9hcHBzLmFwcGxlLmNvbS91cy9hcHAvcmVwdWJsaWMtaW52ZXN0LWluLXN0YXJ0dXBzL2lkMTQ3NTIzMDAyMj9saWQ9ZjdsY3Zhc2VoYTQ0VwNzcGNCCmaSiD2VZhXiXJZSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~ ~/AAQRxQA~/RgRod8KIP0RaaHR0cHM6Ly9wbGF5Lmdvb2dsZS5jb20vc3RvcmUvYXBwcy9kZXRhaWxzP2lkPWNvbS5yZXB1YmxpY21vYmlsZSZobD1lbl9VUyZsaWQ9YXUwNm1zNWcwOWV5VwNzcGNCCmaSiD2VZhXiXJZSG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~   Private equity investing could be risky—learn more. This email was sent by Republic. Crowdfunding investments can result in total loss, and may be impossible to resell. Read about risks. Republic Core LLC ("Core") provides technology and support services to OpenDeal Inc. and its affiliates (collectively, the "Republic Ecosystem"). Republic Note holders and as well as users of the site and services maintained by the Republic Ecosystem, regardless of and their activities on or relating to the Republic Ecosystem, are subject to the applicable terms of service, in their entirety. Core cannot give investment advice, analysis or recommendations with respect to any securities, and is not a registered broker-dealer, funding portal or investment adviser. Securities offerings displayed by Core may be facilitated by its affiliates in the Republic Ecosystem, OpenDeal Portal LLC d/b/a Republic, or OpenDeal Broker LLC d/b/a The CapitalR, Republic Capital Adviser LLC, Republic Deal Room Advisor LLC, Fig Publishing, Inc. or by a third-party issuer. This email is intended only for accredited investors with a pre-existing relationship with the Republic Ecosystem. Please notify the sender immediately if you have received this email by mistake, then delete it. Private investments are risky and illiquid, never invest more than you can afford to lose, consult with your trusted advisors and do your own diligence before investing. This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed; they do not constitute legal or investment advice. Please notify the sender immediately if you have received this e-mail by mistake, then delete it. No longer interested in new offering launch emails? Adjust your [notification settings](~/AAQRxQA~/RgRod8KIP0QraHR0cHM6Ly9yZXB1YmxpYy5jb20vc2V0dGluZ3Mvbm90aWZpY2F0aW9uc1cDc3BjQgpmkog9lWYV4lyWUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~). [Unsubscribe from all emails](~/AAQRxQA~/RgRod8KIP4QVAmh0dHBzOi8vMDUuZW1haWxpbmJvdW5kcHJvY2Vzc2luZy5jb20vZW5jX3VzZXIvdW5zdWJzY3JpYmU_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~~) 149 E 23rd St #2001, New York, NY 10010